Literature DB >> 20388560

S-sulfonation of transthyretin is an important trigger step in the formation of transthyretin-related amyloid fibril.

Toyofumi Nakanishi1, Masanori Yoshioka, Kazuyoshi Moriuchi, Daisuke Yamamoto, Motomu Tsuji, Takayuki Takubo.   

Abstract

Senile systemic amyloidosis and familial amyloid polyneuropathy are caused by oxidative deposition of conformationally altered transthyretin (TTR). We identified oxidative modification of the 10th cysteine of TTR through S-sulfonation in vitro. Based on mass spectrometric analysis, we determined the spectrophotometric, western blotting, and fluorescent microscopic properties of TTR incubated with and without cysteine-S-sulfonate in acidic (pH 4) and alkaline (pH 8) conditions at 37 degrees. The absorption of the aggregated TTR molecules increased more with incubation time and the concentration of cysteine-S-sulfonate at pH 4 than at pH 8. The Congo red binding to the S-sulfonated TTR at pH 4 was saturated with an apparent Bmax of 2.01 mol per mole of the S-sulfonated TTR and apparent KD of 7.75x10(-6) M. On the other hand, the Bmax of cysteinyl TTR was 1.38, and its KD was 3.52x10(-6) M while the Bmax of reduced TTR was 0.86, and its KD was 2.86x10(-6) M. Moreover, we detected positive amyloid fibril staining using Thioflavin T and Congo red with the S-sulfonated TTR but not with untreated or reduced TTR by microscopic fluorescent analysis. After modification of TTR in vitro, oligomers resisted reduction and denaturation was irreversibly induced, and which contributed differences in the Western blotting patterns obtained with four anti-TTR antibodies. In conclusion, this study showed that the formation of S-sulfonation of TTR through oxidative modifications of the thiol residue on the 10th cysteine of TTR is an important trigger step in the formation of transthyretin-related amyloid fibril. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388560     DOI: 10.1016/j.bbapap.2010.03.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Time for new imaging and therapeutic approaches in cardiac amyloidosis.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Walter Noordzij; Johan Bijzet; Bouke P C Hazenberg; Hans L A Nienhuis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-23       Impact factor: 9.236

2.  Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation.

Authors:  Jinping Liu; Jie Lan; Peng Zhao; Fang Zheng; Jingjing Song; Peilan Zhang; Xuguo Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  Two distinct aggregation pathways in transthyretin misfolding and amyloid formation.

Authors:  Anvesh K R Dasari; Ivan Hung; Zhehong Gan; Kwang Hun Lim
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2018-10-24       Impact factor: 3.036

4.  Commentary: Sulfur Dioxide Contributes to the Cardiac and Mitochondrial Dysfunction in Rats.

Authors:  Salvatore Chirumbolo; Geir Bjørklund
Journal:  Front Cardiovasc Med       Date:  2016-05-26

5.  Systemic amyloidoses and proteomics: The state of the art.

Authors:  Francesca Lavatelli; Andrea di Fonzo; Giovanni Palladini; Giampaolo Merlini
Journal:  EuPA Open Proteom       Date:  2016-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.